Pedro Henrique Reis-Barbosa
4PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 23, 2024
Tirzepatide, a dual receptor agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1, enhances β-cell survival and maintenance markers in obese diabetic ovariectomized mice.Pedro H Reis-Barbosa, Marcia Barbosa Aguila, Carlos A Mandarim-de-Lacerda
|Aug 08, 2024
The dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist tirzepatide effects on body weight evolution, adiponectin, insulin and leptin levels in the combination of obesity, type 2 diabetes and menopause in mice.Pedro H Reis-Barbosa, Ilitch Marcondes-de-Castro, Thatiany S Marinho
|Jun 26, 2024
Sodium-glucose cotransporter-2 inhibitor (SGLT2i) plus glucagon-like peptide type 1 receptor combination is more effective than SGLT2i plus dipeptidyl peptidase-4 inhibitor combination in treating obese mice metabolic dysfunction-associated steatotic liver disease (MASLD).Pedro H Reis-Barbosa, Carlos A Mandarim-de-Lacerda
|Jul 13, 2023
AMPK/mTOR pathway significance in healthy liver and non-alcoholic fatty liver disease and its progression.Ilitch Aquino Marcondes-de-Castro, Pedro Henrique Reis-Barbosa, Thatiany Souza Marinho
Pageof 1
